Ads
related to: amgen- Astellas Pharma Support
Learn about our Support Solutions
and find helpful enrollment forms.
- Science and Innovation
View our approach to finding
solutions for cancer's complexities
- World-Class Products
Discover more about our FDA-
approved treatment options.
- Patient Commitment
Our Patient Centricity Team aims to
change the course of cancer care.
- Astellas Pharma Support
Search results
FDA approves Amgen's treatment for most deadly form of lung cancer
CNBC· 2 hours agoThe Food and Drug Administration on Thursday approved Amgen's therapy for patients with the most...
US FDA approves Amgen drug for small cell lung cancer
Reuters via Yahoo News· 2 hours agoThe therapy, marketed under the name Imdelltra, is part of Amgen's pipeline of bispecific...
Amgen Drug Wins US Approval for Advanced Small Cell Lung Cancer
Bloomberg· 3 hours agoAmgen Inc. won US approval for a new drug to treat a particularly aggressive form of advanced lung...
Amgen and Sandoz Settle Denosumab BPCIA Litigation | JD Supra
JD Supra· 15 hours agoAs we previously reported, in May 2023, Amgen filed a BPCIA complaint in the District of New Jersey alleging infringement based on Sandoz’s denosumab biosimilars of
F.D.A. Approves Drug for Persistently Deadly Form of Lung Cancer
New York Times· 35 minutes agoThe Food and Drug Administration on Thursday approved an innovative new treatment for patients with...
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Finance· 9 hours agoAmgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good...
Amgen Inc's Dividend Analysis
GuruFocus.com via Yahoo Finance· 1 day agoAmgen Inc (NASDAQ:AMGN) has recently announced a dividend of $2.25 per share, set to be payable on June 7, 2024, with the ex-dividend date on May 16,...
AMGEN TO HOST CONFERENCE CALL FOLLOWING ATS 2024
FOX 4 Kansas City· 23 hours agoAmgen (NASDAQ:AMGN) will host a webcasted call for the investment community at 1:00 p.m. PT on Monday, May 20, 2024 following the presentation of new data from TEZSPIRE® in ...
Amgen and Sandoz Settle Prolia® / Xgeva® Biosimilar Litigation | JD Supra
JD Supra· 3 days agoAmgen and Sandoz reached a settlement in Case No. 1:23-cv-02406 (D.N.J.) on April 29 just hours before a New Jersey District Court Judge (Christine...
Amgen Is Working On a Wegovy Competitor -- What It Means for Investors | The Motley Fool
The Motley Fool· 4 days agoNovo Nordisk is one of the clear market leaders -- for now -- thanks to its now-famous therapy,...
